Direct suppression of autoreactive lymphocytes in the central nervous system via the CB2 receptor - Wikidata - awgldk - TriplyDB

Direct suppression of autoreactive lymphocytes in the central nervous system via the CB2 receptor

Direct suppression of autoreactive lymphocytes in the central nervous system via the CB2 receptor

http://www.wikidata.org/entity/Q36416340

about

Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities What we know and do not know about the cannabinoid receptor 2 (CB2)Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke.CB2: a cannabinoid receptor with an identity crisis CB2 Cannabinoid receptors as a therapeutic target-what does the future hold?Intrinsic up-regulation of 2-AG favors an area specific neuronal survival in different in vitro models of neuronal damage.Modulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injury Neuroimmune interactions and pain: focus on glial-modulating targets Emerging strategies for exploiting cannabinoid receptor agonists as medicines.Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS CB2 cannabinoid receptors: new vistas.

P2860

Q24623282-94E3B516-B3E0-4D6F-8139-196D1B5AE4FE Q27686851-1F804D17-7182-4870-824E-DC7EF25B5EF8 Q33793559-FC092CF6-49AB-4793-B58A-19E7BADF759E Q34098185-2DC42C31-BC1F-4C67-BEF2-519775F1C17C Q34186015-42252287-F6CF-414B-8912-45986F38F259 Q34531690-B7DE1503-4F6F-44ED-A1D2-6DE01FB3ED56 Q35606180-23074947-1ABF-47BB-AB73-A71BD212C8FF Q37207178-E0534826-8C32-4349-B024-32A490B88992 Q37230665-F60F6C50-1F32-4FF5-B556-22F4678044C0 Q37531460-38913882-DCB1-4AF5-A6B2-3D1AAFEA4EFB Q45854330-0F246554-D554-4AC5-8439-AF27F2041AD5

P2860

Direct suppression of autoreactive lymphocytes in the central nervous system via the CB2 receptor

http://www.wikidata.org/entity/Q36416340

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Direct suppression of autoreac ...... us system via the CB2 receptor

@ast

Direct suppression of autoreac ...... us system via the CB2 receptor

@en

type

label

Direct suppression of autoreac ...... us system via the CB2 receptor

@ast

Direct suppression of autoreac ...... us system via the CB2 receptor

@en

prefLabel

Direct suppression of autoreac ...... us system via the CB2 receptor

@ast

Direct suppression of autoreac ...... us system via the CB2 receptor

@en

P1433

Q36416340-32DD062E-08A5-40E8-BD82-D9A75079D3A3

P1476

Q36416340-07E99648-A823-4AAC-B42A-705AF30A3BA9

P2093

Q36416340-A7353E5B-486C-4581-8EA8-67BDC2B1BCA6

P2860

Q36416340-015F0FC2-48F1-40CE-8AA7-5756F8979913

Q36416340-13F05E38-6304-47CB-B193-1DC723D23463

Q36416340-1467F04D-E258-44CF-98F4-DD85A179C7AE

Q36416340-1577FF84-10A0-4531-96A0-318B73E4D2B7

Q36416340-226A2119-99D1-4159-BB5C-0EC3E9AA892E

Q36416340-2E5775CB-A0AA-4AAF-A468-CCBAC3195BB4

Q36416340-4085AF95-F1AC-4FF7-8586-EE3FEE40A6F0

Q36416340-46B9935F-CE0D-4B37-A284-DF64C83B1B41

Q36416340-49A69CCC-CE51-4928-A2ED-136F674922D0

Q36416340-503B8274-EF36-4B23-A583-DC456F7056CE

P304

Q36416340-9997CBC4-645F-4DA0-9307-5625A77F32C9

P31

Q36416340-A5BAA7D3-44CA-49AF-8052-7B2FEB937033

P356

Q36416340-D4C5C97C-FEBF-48F1-A126-07F75187E870

P407

Q36416340-78C6BCDA-1976-4524-A439-C87B325C42DF

P433

Q36416340-498C4F33-DE83-4AFE-BFD4-20252C107EEE

P478

Q36416340-EEFB5E6A-BD57-42B1-A2E7-FD622B94F40B

P577

Q36416340-A3D30E69-A1BA-40F2-965C-E4D231566B26

P5875

Q36416340-8C1698CE-A914-40ED-81B9-AB6939027552

P698

Q36416340-3B0AEDD1-B871-4A4E-AFA2-8CFE20E8F22C

P921

Q36416340-F3499EF0-21BA-489B-A898-F966085B760F

P932

Q36416340-FE982E0C-6DE7-4F82-A6DC-7682DA066E2C

P356

P1433

British Journal of Pharmacology

P1476

Direct suppression of autoreac ...... us system via the CB2 receptor

@en

P2093

B N Dittel

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

Cannabinoids control spasticity and tremor in a multiple sclerosis model

Endocannabinoids control spasticity in a multiple sclerosis model

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors

Identification and functional characterization of brainstem cannabinoid CB2 receptors

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Molecular characterization of a peripheral receptor for cannabinoids

3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor

P304

271-276

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJP.0707493

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

153

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5923069

http://www.w3.org/2001/XMLSchema#string

P698

17922025

http://www.w3.org/2001/XMLSchema#string

P921

P932

2219523

http://www.w3.org/2001/XMLSchema#string